Preview

Medical alphabet

Advanced search

Clinical experience of treatment patient with papillary thyroid cancer with retropharyngeal lymph node metastasis by targeted therapy

https://doi.org/10.33667/2078-5631-2022-5-15-17

Abstract

The aim. To present a clinical case of treatment of a patient with progressive papillary thyroid cancer in the form of metastatic lesion of the left retropharyngeal lymph node with the targeted drug lenvatinib.

Materials and methods. Clinical, laboratory, radiological and pathomorphological data of a 49-year-old male patient with verified papillary thyroid cancer with disease progression after initial treatment in the form of metastatic lesion of the left retropharyngeal lymph node

Results. A 49-year-old man of European origin, in March 2019, underwent surgical treatment in the volume of thyroidectomy with central and left-sided lateral lymph node dissection followed by radioiodintherapy with 3 Gbc activity for papillary cancer of the left thyroid lobe pT1N 1bM0. In October, according to the control examination, the progression of the disease in the form of metastatic lesion of the left retropharyngeal lymph node was registered. Since February 2020, by appointment of the multidisciplinary commission of the NMRC of Oncology n. a. N. N. Petrov (Moscow, Russia), currently, the patient is taking the targeted drug lenvatinib in a daily dose of 24 mg with satisfactory tolerability. According to control examinations, while taking the drug for 18 months, there was a partial response with a decrease in the size of the left retropharyngeal lymph node from 15 to 7 mm according to magnetic resonance imaging and a decrease in the activity (SUVmax) of the accumulation of 18F-glucose from 10.46 to 5.99.

Conclusion. The presented clinical case demonstrates a rare variant of metastasis of papillary thyroid cancer in the left retropharyngeal node and the result of treatment with the targeted drug lenvatinib on the background of taking for 18 months.

About the Authors

Z. A.-G. Radjabova
National Medical Research Centre of Oncology n. a. N. N. Petrov
Russian Federation

Radjabova Zamira A.-G., PhD Med, associate professor, head of Dept of Head and Neck Tumors

Saint Petersburg, Pesochny Settlement



M. A. Kotov
National Medical Research Centre of Oncology n. a. N. N. Petrov
Russian Federation

Kotov Maxim A., PhD Med, oncologist at Dept of Head and Neck Tumors

Saint Petersburg, Pesochny Settlement



M. A. Radjabova
National Medical Research Centre of Oncology n. a. N. N. Petrov
Russian Federation

Ponomareva Olga I., roentgenologist at Dept. Radiotherapy

Saint Petersburg, Pesochny Settlement



O. I. Ponomareva
National Medical Research Centre of Oncology n. a. N. N. Petrov
Russian Federation

Ponomareva Olga I., roentgenologist at Dept. Radiotherapy

Saint Petersburg, Pesochny Settlement



References

1. Smith V.A., Sessions R.B., Lentsch E.J. Cervical lymph node metastasis and papillary thyroid carcinoma: Does the compartment involved affect survival? Experience from the SEER database. J. Surg. Oncol. John Wiley & Sons, Ltd, 2012. Vol. 106, No. 4. P. 357–362.

2. Pereira J.A. et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery. Mosby, 2005. Vol. 138, No. 6. P. 1095–1101.

3. Zaydfudim V. et al. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery. Mosby, 2008. Vol. 144, No. 6. P. 1070–1078.

4. Thompson A.M. et al. A Preoperative Nomogram for the Prediction of Ipsilateral Central Compartment Lymph Node Metastases in Papillary Thyroid Cancer. Thyroid. Mary Ann Liebert, Inc., 2014. Vol. 24, No. 4. P. 675.

5. Masmoudi M. et al. Parapharyngeal Lymph Node Metastasis From Papillary Thyroid Carcinoma:. https://doi.org/10.1177/01455613211045566. SAGE PublicationsSage CA: Los Angeles, CA, 2021. Vol. 0, No. 0. P. 1–4.

6. Togashi T. et al. Surgical management of retropharyngeal nodes metastases from papillary thyroid carcinoma. World J. Surg. Springer, 2014. Vol. 38, No. 11. P. 2831–2837.

7. Kholmatov R. et al. Locally advanced asymptomatic papillary thyroid cancer presenting with retropharyngeal lymph node metastasis symptoms. Gland Surg. AME Publishing Company, 2017. Vol. 6, No. 6. P. 733–737.

8. Otsuki N. et al. Retropharyngeal node metastasis from papillary thyroid carcinoma. Head Neck. 2007. Vol. 29, No. 5. P. 508–511.

9. Givi B. et al. Transoral robotic retropharyngeal node dissection. Head Neck. John Wiley and Sons Inc., 2016. Vol. 38. P. E981–E986.

10. Hartl D.M. et al. Management of retropharyngeal node metastases from thyroid carcinoma. World J. Surg. Springer New York LLC, 2015. Vol. 39, No. 5. P. 1274–1281.

11. Shellenberger T. et al. Transoral resection of thyroid cancer metastasis to lateral retropharyngeal nodes. Head Neck. 2007. Vol. 29, No. 3. P. 258–266.

12. Togashi T. et al. Surgical management of retropharyngeal nodes metastases from papillary thyroid carcinoma. World J. Surg. 2014. Vol. 38, No. 11. P. 2831–2837.

13. Chen S. et al. Transcervical dissection of metastatic suprahyoid retropharyngeal lymph nodes from papillary thyroid carcinoma through three anatomical barriers. Int. J. Oral Maxillofac. Surg. Churchill Livingstone, 2021. Vol. 50, No. 2. P. 158–162.


Review

For citations:


Radjabova Z.A., Kotov M.A., Radjabova M.A., Ponomareva O.I. Clinical experience of treatment patient with papillary thyroid cancer with retropharyngeal lymph node metastasis by targeted therapy. Medical alphabet. 2022;1(5):15-17. (In Russ.) https://doi.org/10.33667/2078-5631-2022-5-15-17

Views: 178


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)